Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,689 across all filing types
Latest filing 2023-07-03 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
关于调整日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company regarding adjustments to its expected daily related-party transactions. It includes details about the related parties, transaction amounts, pricing principles, and independent directors' opinions. The document is relatively short (3071 characters) and focuses on disclosure of related-party transaction estimates and approvals by the board. It does not contain financial statements, audit opinions, or detailed financial performance data. It is not a full annual or interim report, nor an earnings release or management discussion. It is a regulatory announcement about related-party transactions, which fits best under Regulatory Filings (RNS) as it does not fit other more specific categories.
2023-07-03 Chinese
关于增设经营场所暨修改《公司章程》的公告
Governance Information Classification · 95% confidence The document is an announcement from the company about adding new business premises and amending the company's articles of association. It includes details about the new addresses and proposed changes to the company charter. It also mentions that the board has approved the proposal and that it will be submitted to the shareholders' meeting for approval. The document is relatively short (842 characters) and does not contain financial data, financial statements, or detailed management discussion. It is a regulatory announcement about corporate governance changes but not a full governance report or management report. It is not a report publication announcement since it contains substantive information about the change. The best fitting category is 'Governance Information (CGR)' as it details changes to the company's internal rules (articles of association) and governance structure (business premises and charter amendments).
2023-07-03 Chinese
关于变更董事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding a change in the company's board of directors. It details the resignation of a director, the appointment of a new director, and related compliance and shareholding information. There are no financial statements, earnings data, or report publications. The content focuses on board membership changes and governance compliance. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not a report or announcement of a report publication, so it is not RPA or RNS.
2023-07-03 Chinese
第五届董事会第十七次临时会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of resolutions passed at a board meeting of Dirui Medical Technology Co., Ltd. It details decisions such as the election of directors, adjustments to the audit committee, and amendments to the company bylaws. The text includes voting results and references to further announcements on a regulatory website. There is no financial data, earnings information, or report publication mentioned. The content focuses on board decisions and changes in board composition and committee membership, which aligns with announcements about board or management information. The document length is short (1222 characters), and it is not a report or a notice of report publication but a direct announcement of board meeting resolutions. Therefore, the appropriate classification is Board/Management Information (MANG).
2023-07-03 Chinese
关于公司获得医疗器械注册证暨医疗器械注册证变更的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Dirui Medical Technology Co., Ltd. regarding the acquisition and changes of medical device registration certificates issued by national and provincial drug regulatory authorities. It lists detailed product registration certificate numbers, validity periods, classification, and changes in product names, storage conditions, applicable instruments, technical requirements, and instructions. The document is an official announcement about regulatory approvals and product registration updates, not a financial report, earnings release, or management discussion. It does not contain financial statements or performance data. The document length is 7428 characters, which is sufficient for a detailed announcement. This type of document fits best under Regulatory Filings (RNS) as it is a regulatory announcement about product registration certificates and changes, not a financial or governance report.
2023-07-03 Chinese
关于参股公司首次公开发行股票并在创业板上市申请终止审核的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Dirui Medical Technology Co., Ltd. regarding the termination of the review process for the initial public offering (IPO) and listing application of its associated company, Xiamen Zhishan Biotechnology Co., Ltd., on the Shenzhen Stock Exchange's ChiNext board. It references a previous announcement and the official decision by the exchange to terminate the IPO review. The document is short (598 characters) and serves as an official notice about a regulatory event related to the IPO process, not a financial report or detailed filing. It does not contain financial statements or detailed analysis but is a regulatory announcement about the status of a listing application. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-06-30 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.